Strategic Partnerships Leverage Menarini Asia-Pacific’s existing licensing and distribution collaborations (for example with Pharmacosmos and Astellas) to identify co-marketing or regional expansion opportunities for complementary therapies, diagnostics, or patient-support programs across Asia-Pacific.

Pipeline Expansion Target opportunities related to the group’s active oncology and specialty care portfolio, including Cosela in Asia-Pacific and JAK inhibitor peficitinib in Taiwan, to pursue regional registrations, supply deals, or value-added services in clinical development, regulatory affairs, and lifecycle management.

Digital Tools Position Menarini Connect and other digital platforms as channels for payer engagement, patient access programs, and data-driven marketing, offering partnerships to enhance digital health services, remote monitoring, and telemedicine support in APAC markets.

Market Access Explore joint market access and reimbursement opportunities leveraging the group’s broad therapeutic fields (cardio-metabolic, dermatology, infectious disease, oncology) to craft bundled solutions, patient assistance, and pricing strategies tailored to APAC regulatory landscapes.

Sustainable Growth Align with Menarini’s multi-therapeutic portfolio and regional footprint to propose strategic alliances with local manufacturers, contract research and manufacturing organizations, or distribution partners to accelerate launches, improve supply chain resilience, and expand patient reach in key APAC markets.